3月21日,伊诺维奥制药(INO.US)公布财报,公告显示公司2024财年净利润为-1.07亿美元,同比增加20.74%;其中营业收入为217756.00美元,同比减少73.83%,每股基本收益为-3.95美元。从资产负债表来看,伊诺维奥制药(INO.US)总负债46.40百万美元,其中短期债务2.50百万美元,资产负债比为0.03,流动比率为2.77。机构评级:截至2025年3月21日,当前有6...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.